Psychedelics startups are on a long journey to consumer markets, but these 5 VCs are taking the ride
TechCrunch
MAY 4, 2022
According to the World Health Organization, the global prevalence of anxiety and depression increased by a massive 25% in the first year of the pandemic. What are you more bullish about: Companies directly involved in developing and/or delivering psychedelics, or ancillary and infrastructure companies? To a degree, yes.
Let's personalize your content